REVERSED INNOVATION
We find new indications
for existing technologies
THE MEANING OF
REVERSED INNOVATION
We find new indications for existing technologies.
Through our research, we work relentlessly to improve lives by addressing unmet medical needs.
Reversed Innovation is our core value.
As a leader in the biopharmaceutical industry, reversed innovation aligns with the broader theme, as we take an existing product or technology and use it to address a new or previously overlooked or unconsidered medical problem or condition.
TRUSTED DEVELOPMENT
Dr. Claus J. Møller-San Pedro is the company CEO.
Dr. Møller co-founded and secured successful IPOs of 3 companies in the BioPharma Industry: OXiGENE Inc. (OTLC); Genmab A/S (GMAB) and Y-mAbs Therapeutics, Inc. (YMAB).
Our latest investor presentation is always available here together with annual reports, financial information and other news from AFYX.
NEWS
Genmab founder dreams again of IPO of biotech company
After a sudden exit from Y-Mabs Therapeutics, Claus Møller has been quite silent for two years. Now he is building a new biotech company. Claus Møller, who helped found Genmab, has now started a new biotech adventure with Afyx Therapeutics. Claus Møller-San Pedro, who...
AFYX completes financing round of DKK 13.7M
Hørsholm, Denmark, April 15, 2024 After our recent Annual General Meeting the BOD has now in cooperation with the CEO completed an internal financing round to secure the financial basis for the transformation of our company to become an international growth and...
AFYX report from our Annual General Meeting
Hørsholm, Denmark, April 03, 2024 As of August 2023, Dr. Claus Møller-San Pedro took over as the new CEO of Inphena ApS, now a part of AFYX Therapeutics A/S. During an Extraordinary General Meeting in December 2023 our Board of Directors (BOD) was expanded to 3...
AFYX THERAPEUTICS HQ
Agern Alle 24
DK-2970 Hørsholm
Denmark
VAT: 38793594
Phone: +45 7174 7174
info@afyxtx.com
INPHENA NORWAY
Gaustadalléen 21
NO-0349 Oslo
Norway
VAT: 922 558 221
Phone: +47 2396 7174